Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rHuKGF to Prevent Acute GVHD in Bone Marrow Transplant Recipients
NCT00031148Phase 2Completed
- Sponsor
- Food and Drug Administration
- Start
- Sep 2001
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2 trial of human keratinocyte growth factor in graft-versus-host disease (GVHD), sponsored by Food and Drug Administration. Primary endpoint: Overall Graft-Versus-Host Disease Grade. Started Sep 2001; status: completed.
02
Drugs
human keratinocyte growth factor
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00031148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031148.